BioCentury | Mar 19, 2007
Clinical News

Erdosteine: Preliminary Phase IIb data

...to determine the ultimate outcome of the study. Adams Respiratory Therapeutics Inc. (ARXT), Chester, N.J. Edmond Pharma s.r.l....
BioCentury | Nov 13, 2006
Clinical News

Erdosteine: Completed Phase IIb enrollment

...IIb trial. ARXT in-licensed the compound from Edmond Pharma. Adams Respiratory Therapeutics Inc. (ARXT), Chester, N.J. Edmond Pharma s.r.l....
BioCentury | Apr 3, 2006
Clinical News

Erdosteine: Phase II started

...disorder (COPD). ARXT in-licensed the compound from Edmond Pharma. Adams Respiratory Therapeutics Inc. (ARXT), Chester, N.J. Edmond Pharma...
BioCentury | Apr 26, 2004
Company News

Provalis, Edmond Pharma SpA deal

...PRO will distribute Erdotin erdosteine from Edmond Pharma in the U.K. and Ireland for at least 10...
...development and regulatory costs. Erdotin is undergoing European registration. Provalis plc (LSE:PRO; PVLS), Deeside, U.K. Edmond Pharma...
Items per page:
1 - 4 of 4
BioCentury | Mar 19, 2007
Clinical News

Erdosteine: Preliminary Phase IIb data

...to determine the ultimate outcome of the study. Adams Respiratory Therapeutics Inc. (ARXT), Chester, N.J. Edmond Pharma s.r.l....
BioCentury | Nov 13, 2006
Clinical News

Erdosteine: Completed Phase IIb enrollment

...IIb trial. ARXT in-licensed the compound from Edmond Pharma. Adams Respiratory Therapeutics Inc. (ARXT), Chester, N.J. Edmond Pharma s.r.l....
BioCentury | Apr 3, 2006
Clinical News

Erdosteine: Phase II started

...disorder (COPD). ARXT in-licensed the compound from Edmond Pharma. Adams Respiratory Therapeutics Inc. (ARXT), Chester, N.J. Edmond Pharma...
BioCentury | Apr 26, 2004
Company News

Provalis, Edmond Pharma SpA deal

...PRO will distribute Erdotin erdosteine from Edmond Pharma in the U.K. and Ireland for at least 10...
...development and regulatory costs. Erdotin is undergoing European registration. Provalis plc (LSE:PRO; PVLS), Deeside, U.K. Edmond Pharma...
Items per page:
1 - 4 of 4